BACKGROUND: The etiology of meningioma, the second most common type of adult brain tumor in the United States, is largely unknown. Prior studies indicate that history of immune-related conditions may affect the risk of meningioma. METHODS: To identify genetic markers for meningioma in genes involved with innate immunity, we conducted an exploratory association study of 101 meningioma cases and 330 frequency-matched controls of European ancestry using subjects from a hospital-based study conducted by the National Cancer Institute. We genotyped 1,407 "tag" single nucleotide polymorphisms (SNP) in 148 genetic regions chosen on the basis of an r2>0.8 and minor allele frequency of >5% in Caucasians in HapMap1. Risk of meningioma was estimated by odds ratios and 95% confidence intervals. RESULTS: Seventeen SNPs distributed across 12 genetic regions (NFKB1 (3), FCER1G (3), CCR6 (2), VCAM1, CD14, TNFRSF18, RAC2, XDH, C1D, TLR1/TLR10/TLR6, NOS1, and DEFA5) were associated with the risk of meningioma with P<0.01. Although individual SNP tests were not significant after controlling for multiple comparisons, gene region-based tests were statistically significant (P<0.05) for TNFRSF18, NFKB1, FCER1G, CD14, C1D, CCR6, and VCAM1. CONCLUSIONS AND IMPACT: Our results indicate that common genetic polymorphisms in innate immunity genes may be associated with risk of meningioma. Given the small sample size, replication of these results in a larger study of meningioma is needed. Copyright (c) 2010 AACR
BACKGROUND: The etiology of meningioma, the second most common type of adult brain tumor in the United States, is largely unknown. Prior studies indicate that history of immune-related conditions may affect the risk of meningioma. METHODS: To identify genetic markers for meningioma in genes involved with innate immunity, we conducted an exploratory association study of 101 meningioma cases and 330 frequency-matched controls of European ancestry using subjects from a hospital-based study conducted by the National Cancer Institute. We genotyped 1,407 "tag" single nucleotide polymorphisms (SNP) in 148 genetic regions chosen on the basis of an r2>0.8 and minor allele frequency of >5% in Caucasians in HapMap1. Risk of meningioma was estimated by odds ratios and 95% confidence intervals. RESULTS: Seventeen SNPs distributed across 12 genetic regions (NFKB1 (3), FCER1G (3), CCR6 (2), VCAM1, CD14, TNFRSF18, RAC2, XDH, C1D, TLR1/TLR10/TLR6, NOS1, and DEFA5) were associated with the risk of meningioma with P<0.01. Although individual SNP tests were not significant after controlling for multiple comparisons, gene region-based tests were statistically significant (P<0.05) for TNFRSF18, NFKB1, FCER1G, CD14, C1D, CCR6, and VCAM1. CONCLUSIONS AND IMPACT: Our results indicate that common genetic polymorphisms in innate immunity genes may be associated with risk of meningioma. Given the small sample size, replication of these results in a larger study of meningioma is needed. Copyright (c) 2010 AACR
Authors: P D Inskip; R E Tarone; E E Hatch; T C Wilcosky; W R Shapiro; R G Selker; H A Fine; P M Black; J S Loeffler; M S Linet Journal: N Engl J Med Date: 2001-01-11 Impact factor: 91.245
Authors: L Bello; J Zhang; D C Nikas; J F Strasser; R M Villani; D A Cheresh; R S Carroll; P M Black Journal: Neurosurgery Date: 2000-11 Impact factor: 4.654
Authors: Preetha Rajaraman; Alina V Brenner; Mary Ann Butler; Sophia S Wang; Ruth M Pfeiffer; Avima M Ruder; Martha S Linet; Meredith Yeager; Zhaoming Wang; Nick Orr; Howard A Fine; Deukwoo Kwon; Gilles Thomas; Nathaniel Rothman; Peter D Inskip; Stephen J Chanock Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-05 Impact factor: 4.254
Authors: Ellen T Chang; Brenda M Birmann; Julie L Kasperzyk; David V Conti; Peter Kraft; Richard F Ambinder; Tongzhang Zheng; Nancy E Mueller Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-02-17 Impact factor: 4.254
Authors: Danielle M Backes; Afshan Siddiq; David G Cox; Federico C F Calboli; J Michael Gaziano; Jing Ma; Meir Stampfer; David J Hunter; Carlos A Camargo; Dominique S Michaud Journal: J Neurooncol Date: 2013-03-25 Impact factor: 4.130
Authors: Meredith S Shiels; Eric A Engels; Jianxin Shi; Maria Teresa Landi; Demetrius Albanes; Nilanjan Chatterjee; Stephen J Chanock; Neil E Caporaso; Anil K Chaturvedi Journal: Cancer Date: 2012-10-08 Impact factor: 6.860
Authors: E N Rogers; D Z Jones; N C Kidd; S Yeyeodu; G Brock; C Ragin; M Jackson; N McFarlane-Anderson; M Tulloch-Reid; K Sean Kimbro; L R Kidd Journal: Genes Immun Date: 2013-05-09 Impact factor: 2.676